HIV.gov
CDC Infographic stating that "Not all women and girls living with HIV are getting the care they need."

NIH’s Dr. Gina Brown on Highlights of Research on Women & HIV from CROI 2018

3-9-2018As we prepare to observe National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) on March 10, we wanted to share this video of our recent conversation with NI…
Anne Rancour and Carl Dieffenbach

Final HIV Research Highlights from CROI 2018 (2 Videos)

3-8-2018Our coverage from the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston wrapped up yesterday with two interviews with Federal HIV le…
Anne Rancour and Dr Laura Cheever on the set for Facebook Live at CROI

More HIV Research Highlights from CROI 2018 (Videos)

3-7-2018Our coverage from the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston continued yesterday with three interviews with Federal HIV l…
This graphic depicts a pie chart that illustrates the percentage of African Americans and Latinos who could benefit from pre-exposure prophylaxis (PrEP): 44 percent of African Americans (approximately 500,000 people) and 25 percent of Latinos (nearly 300,

HIV Prevention Pill not Reaching Most Americans Who Could Benefit – Especially People of Color

3-6-2018A new CDC analysis suggests that only a small percentage of Americans who could benefit from pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention, h…
Dr. Dieffenbach, the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) speaks on camera with his colleague Anne Rancourt

HIV Research Highlights from First Day of CROI 2018 (Video)

3-6-2018Advances in HIV research are being shared this week at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, and HIV.gov is here sh…
nih logo

One-Month Tuberculosis Prophylaxis as Effective as Nine-Month Regimen for People Living with HIV

3-5-2018A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people livi…

Pages